Tata Elxsi Launches Global ODC for Terumo Corporation
Filing Summary
On March 19, 2026, Tata Elxsi announced the launch of a Global Offshore Development Center (ODC) for Terumo Corporation. The center, located in Pune, India, will focus on developing cardiac and vascular solutions. It combines Tata Elxsi’s expertise in design, engineering, and regulatory compliance with advanced AI and digital capabilities. This collaboration aims to enhance Terumo’s product development and lifecycle support across international markets. The ODC will facilitate the adaptation of medical devices to regional needs, ensuring compliance with industry standards.
On March 19, 2026, Tata Elxsi announced the inauguration of a Global Offshore Development Center (ODC) for Terumo Corporation in Pune, India. This center is dedicated to supporting the development of Terumo’s cardiac and vascular solutions. It aims to enhance engineering and innovation capabilities while providing continuous lifecycle support across international markets.
The ODC integrates multidisciplinary teams, leveraging Tata Elxsi’s expertise in design, engineering, verification, regulatory compliance, and localization. The application of AI, GenAI, and digital capabilities in software engineering is a key feature, enabling faster development and regional adaptation of medical devices. This approach addresses the demand for patient-centric solutions with improved cost efficiency and product differentiation.
The collaboration between Tata Elxsi and Terumo Corporation focuses on advancing the reliability and performance of cardiac and vascular technologies. The center supports the global availability of these technologies, ensuring they meet industry standards and the evolving needs of healthcare providers and patients.
Fumihisa Hirose, Company President of Cardiac & Vascular Company at Terumo Corporation, highlighted the center’s role in accelerating innovation and delivering high-quality medical technologies globally. Tata Elxsi’s integrated design, engineering, and regulatory expertise is expected to aid in advancing Terumo’s global product roadmap while maintaining safety and compliance standards.
Sreevatsa Sahasranaman, Senior Vice President & Head of Healthcare & Life Sciences at Tata Elxsi, emphasized the long-term partnership model with Terumo Corporation. The collaboration aims to drive innovation and cost efficiencies across Terumo’s cardiovascular portfolio, utilizing Tata Elxsi’s multi-disciplinary expertise and AI-powered technologies.
Terumo Corporation is a global medical innovation company focusing on cardiac and vascular solutions. It collaborates with partners to enhance the development and availability of medical technologies worldwide.
Tata Elxsi is a global design and technology services company. It supports industries such as healthcare, automotive, broadcast, and communications through design studios, development centers, and innovation hubs worldwide. The company is committed to advancing next-generation product development in collaboration with global medical device and pharmaceutical companies.